AUCTORES
Globalize your Research
Review Article | DOI: https://doi.org/10.31579/2693-2156/056
1 Department of Cardiovascular Surgery, Shenzhen People's Hospital, Shenzhen 518020, Guangdong, China; The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen 518020, Guangdong, China.
2 Department of Cardiovascular Surgery, The First Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, China
3 Department of Cardiovascular Surgery, The 2nd Clinical Medical College (Shenzhen People's Hospital) of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, 518020, China.
*Corresponding Author: Qijun Zheng, Department of Cardiovascular Surgery, Shenzhen People's Hospital, Shenzhen 518020, Guangdong, China; The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen
Citation: Qijun Zheng, Xiaoying Zhu, Xiong Jia, Yayu Wang, (2023), Current Progress in Multi-Omics Studies of Aortic Dissection, J Thoracic Disease and Cardiothoracic Surgery, 5(1); DOI:10.31579/2693-2156/056
Copyright: Qijun Zheng, Xiaoying Zhu, Xiong Jia, Yayu Wang, (2023), Current Progress in Multi-Omics Studies of Aortic Dissection, J Thoracic Disease and Cardiothoracic Surgery, 5(1); DOI:10.31579/2693-2156/056
Received: 03 March 2023 | Accepted: 10 March 2023 | Published: 20 March 2023
Keywords: aortic dissection; genomics; epigenomics; transcriptomics; proteomics
Aortic dissection (AD) is a cardiovascular disease with a high mortality rate. With the rapid development of genetic testing technology, genomics can be used to predict, diagnose and treat AD. In this review, we summarize studies on AD using the genome, epigenome, transcriptome, proteome and metabolome. Multi-omics analysis can further clarify the mechanisms of AD and provide risk assessment techniques. Although related studies on the different omics of AD have been conducted, the combined analysis of multiple omics has not been studied in depth. In this paper, we will conduct an in-depth discussion of AD research using multiple omics.
Aortic dissection (AD) is a rare but life-threatening cardiovascular condition associated with high morbidity and mortality rates and is one of the main diseases affecting the aorta.[1] AD involves the separation of layers that create a false lumen within the aortic wall. The force of blood pumping can split the layers of the arterial wall and, allow blood to leak between them, in a process called dissection, which can disrupt or interrupt the blood supply to vital organs.[2] If the tear occurs in the ascending aorta, in the front of the chest, it is classified as a type A dissection. If it occurs in the descending aorta, it is classified as a type B dissection. According to incomplete statistics, the annual incidence of aortic dissection in 65-75 years old is 17.4/100000,[3,4] and 200000 new cases are diagnosed in China yearly. However, AD patients have a mortality rate of up to 80% within a week in the absence of emergency treatment.[5] The main treatment methods are drug therapy and surgical repair, however, the mortality rate of surgery is as high as 10%-35%, and there are other sequelae. As the clinical manifestation of AD lacks specificity, the rate of initial misdiagnosis of AD is 14.1% in patients diagnosed with this devastating clinical event.[6] Therefore, exploring potential biomarkers of AD is crucial for early detection and treatment to reduce mortality.The etiology and pathogenesis of AD remain unclear. Essential hypertension, hardening external injury, smoking, pheochromocytoma, and inflammatory alterations may increase the susceptibility to major pulse-related diseases in many patients. In addition, poorly controlled high blood pressure is a major risk factor for aortic clamping,[7–9] and approximately 80% of patients with AD have hypertension. Furthermore, genetic factors also play acrucial role in the etiology of AD. Currently, the diagnosis of AD still relies on imaging techniques, of which contrast-enhanced Computed Tomography (CT) is the most widely used.[7] However, patients with AD require braking and sedation, which limits the use of contrast-enhanced CT. Therefore, the assessment of risk factors, detection of biomarkers and identification of inherited gene mutations are of great importance for predicting the risk and reducing the mortality rate of AD. Since the beginning of this century, the development of high-throughput (omics) techniques, including genomics, transcriptomics, proteomics, metabolomics and computational resources has importantly increased our understanding of AD.
Genomics:
An organism's complete set of DNA is called its genome. Virtually every single cell in the body contains a full copy of the approximately 3 billion DNA base pairs, that make up the human genome.[10] Genomics is the study of a person's genes (the genome), including interactions of those genes with each other and with the person's environment.[8] Genomic sequencing technologies mainly include whole-exon sequencing (WES),[11] whole genome sequencing (WGS), and DNA microarray technology.[12] Genomics pioneered the era of omics and is also the foundation of multi-omics.Currently, the pathogenesis of AD from the perspective of gene variation can be divided into two categories: simple nucleotide variations (SNVs) and structural variations (SVs).[13] The SNVs can be further divided into single nucleotide variations and small insertions/deletions (indels). SVs are generally defined as deletions (DELs), insertions (INSs), duplications (DUPs), inversions (INVs), or translocations (TRAs) at least 50 bp in size.[14] Previous studies have shown that the complex genetic background of AD is mostly related to connective tissue diseases, such as Marfan syndrome (MFS) induced by the FBN1 gene[15,16] Ehlers-Danlos syndrome caused by heterozygous mutations in the COL3A1 gene, which encodes type III collagen (COLL III);[17,18] Loeys-Dietz syndrome caused by heterozygous missense mutations in either the TGF-β receptor gene (TGFBR1) or TGFBR2;[19] Shprintzen-Goldberg syndrome caused by SKI (V-Ski avian sarcoma viral oncogene homolog).[20]
Heredity gene in AD
Thoracic aortic dissection (TAD) occurs in the thoracic region, mainly in middle and old age; most of which are sporadic.[21,22] Several studies have reported the importance of inherited factors in the development of non-integrated thoracic aortas, with a heritability of approximately 70%,[23] and 20%-40% of TAD patients have a family history.[24] A study at Yale University, which sequenced 15 genes in 1025 European patients with TAD in the second generation, found that almost half of those with pathogenic or potentially pathogenic variants were non-syndromal and had no family history of AD.[25] In many affected families, AD is inherited in an autosomal dominant manner with decreased penetrance and variable expressivity.[26] Mutations in 13 genes have been confirmed to be related to the disease in approximately 30% of affected families. Wallace et al assessed the effect of MYLK missense mutation on myosin light-chain kinase (MLCK) activation in 60 patients and found that AD developed earlier in the patients with this mutation.[27]The main risk factors for AD are hypertension and underlying genetic alterations. Genetic changes have been found to help identify the pathogenesis, early detection and early treatment of AD.
Related pathogenic genes of AD
To date, at least a dozen genes may be associated with AD, such as FBN1,[28] FOXE3,[29] LTBP3,[30] PRKG1,[31] CDK1,[32] and TGFB2.[33] The extracellular matrix (ECM) glycoprotein encoded by FBN1 is an integral part of the elastic fiber of AD.[34] The loss of microfibers and the damage to elastic fibers lead to thinning and brittleness of the aortic wall, which is one of the most important motile causes of AD. FBN1 also plays a role in regulating the bioavailability of TGF-β. The loss of FBN1 promotes the release of a large amount of active TGF-β1 in the ECM, leading to excessive activation of the TGF-β signaling pathway and accelerating the destruction of the ECM.[35] The elastic fibers of aortic wall cells become thinner and more fragile, AD occurrence.
Although many mechanisms have not been identified yet, the pathogenesis of AD will progress with the development and improvement of genomics and sequencing technology, laying a foundation for the development of precision medicine.
Epigenomics
Epigenomics refers to changes in gene expression levels based on non-gene sequence changes, including DNA methylation, histone modifications, chromosomal remodeling, and noncoding RNA regulation;[36] mainly by regulating transcription or translation process, and affecting gene function and characteristics. Individual epigenetic recognition aids in cardiovascular disease diagnosis, prediction, prognosis, biomarkers and drug target selection.[37] DNA methylation
DNA methylation is a process in which cytosine is converted to 5-methyl cytosine catalyzed by DNA methyltransferase.[38] It is a direct chemical modification of DNA without changing the DNA sequence and is closely related to gene expression regulation.[39] The aortic tissues of AD patients and healthy individuals as controls were examined by whole-genome bisulfite sequencing (WGBS). Epigenetic regulatory changes related to the vascular system and heart development, causing changes in gene expression, have been found in AD cases. For example, epigenetics changes in the Hox family genes may lead to loss of aortic integrity and AD pathogenesis.[40] Another recent study also identified 28 differentially methylated positions (DMPs) in Marfan syndrome, which were significantly correlated with aortic diameter in patients with MFS. Seven of these DMPs (25%) could be assigned to genes previously associated with cardiovascular disease (HDAC4, IGF2BP3, CASZ1, SDK1, PCDHGA1, DIO3, PTPRN2).[41]
Histone modification
Histone modifications include methylation, acetylation and ubiquitination phosphorylation pathways, which affect the occurrence and development of AD by targeted transcriptional regulation of the AD gene at the transcriptional level.[42] In recent years, the intracellular downstream effectors of the TGF-β ligands TGFB2 and TGFB3 and the TGF-β pathways SMAD2 and SMAD3 have been shown to affect cardiovascular connective tissue disease, leading to aortic aneurysms and varicoses.[43] Overexpression of SMAD2 in these vascular smooth muscle cells (VSMCs) was subsequently shown to be regulated by histone acetyltransferase (P300/PCAF).[44]Therefore, abnormal TGF-β signaling frequently observed in gene-triggered AD may be associated with aberrant histone regulation affecting SMAD2 transcription.
Transcriptomics
The term transcriptome implies the complete set of all the ribonucleic acid (RNA) molecules expressed in some given entity, such as a cell, tissue, or organism.[45] This process links the genome, proteome, and cellular phenotype.[46] After genome sequencing, transcriptomics analysis enables understanding genome expression at the transcriptional level, providing information on gene structure, regulation of gene expression, gene product function and genome dynamics.[47] New biomarkers at the transcriptome level may lead to earlier diagnosis time and higher specificity compared to previously known markers and inflammatory factors. Noncoding RNAs (ncRNAs) such as short-noncoding RNAs and long-noncoding RNAs are emerging as new fundamental regulators of gene expression.
microRNA
MicroRNAs (miRNAs) are endogenous ncRNAs that are approximately 20-25 nucleotides long and play essential roles in regulating pathophysiological functions, such as differentiation, proliferation, migration and apoptosis.
The change in miRNA expression level is related to the occurrence of different diseases, such as miR-135a-3p, miR-200c, miR-216a and miR-340, which modulate the invasiveness of ovarian cancer cell[48] and miR-143/145 in cardiovascular diseases.[49] Over the past decade, several miRNAs have been shown to regulate vascular remodeling,[50] and to target endothelial cells, smooth muscle cells and immune cells in the vasculature to alter the pathophysiology of the aorta. miRNA-21 regulates SMAD7 expression, affects typical TGF-β signal transduction, and participates in the formation of AD.[51] In addition, some experiments have confirmed the decreased expression of miR-145 in ascending aorta specimens of AD.[49] miR-320 can regulate the expression of matrix metalloproteinases (MMP) after transcription. MMP overexpression contributes to ECM degradation, thus affecting AD progression.[52] In a BAPN(3-Aminopropionitrile fumarate)-induced mouse AD model, inhibition of miR-144-3p expression resulted in a reduced incidence of AD from 90% to 50%. In addition to the mouse model, miR-30A expression is significantly upregulated in human AD ascending aorta specimens[53]. Other miRNAs include microRNA-146b (miR-146b)[54], microRNA146a-5p (miR-146a-5p)[55], and microRNA-143/145[56]. They are biomarkers for AD diagnosis, which can predict the risk of AD, assess prognosis, and serve as a basis for choosing the timing of surgery.
Recently, researchers analyzed exosomal miRNAs in the plasma of AD patients and found 283 specific microRNAs.[55] They analyzed the previous ten and lower ten miRNAs and found that the plasma exosomal microRNAs were mainly involved in the pathogenesis of AD with acute lung injury (ALI) by recruitment of immune cells, expanding inflammatory response, breaking cell connections and the framework. For example, miR-206 is related to lung tissue inflammation in ALI and miR-485-5p may participate in AD with ALI by regulating inflammation and promoting lung capillary endothelial injury.
Long non-coding RNAs (lncRNAs)
Long non-coding RNAs (lncRNAs), generally 200 nt long, are reported to be three-dimensional (3D) regulators of transcription and translation by acting as molecular decoys and scaffolds or by binding guide ribonucleoprotein complexes to their targets. In recent years, lncRNAs have been found to play an important role in the occurrence and development of cardiovascular diseases.[57] Most of these have significant spatiotemporal expression and specificity during tissue differentiation and development, making them good biomarkers for the diagnosing of AD.
Proteomics
The proteome is the whole complement of proteins, including modifications made to a certain set of proteins, produced by the organism. Proteomics stability is required to ensure the proper function of cells and organisms.[58] Proteomics can be defined as a large-scale study of protein properties, aimed at studying the whole proteome or the sum of all proteins from an organism, tissue, cell, biofluid, or a subfraction thereof.[59,60]
In recent years, progress has been made in the study of AD based on proteomics. Deng et al used isobaric tags for relative and absolute quantitation (iTRAQ) and label-free analysis, to compare the differences in protein expression profiles in ascending aortic wall specimens of AD patients and normal individuals as controls.[61] This study identified and validated that Lumican, PI16, MMP9, and FGL1 proteins may be a potential biomarker in patients with AD. The pathogenesis of AD may be related to the lumican-mediated TGF-1 pathway. In addition, in another label-free proteomics study, vinculin expression was significantly increased in aortic tissue samples and the concentration of vinculin increased in both type A and B dissection.[62] In both of these studies, serum samples were used, but aortic wall samples could also be used. Tandem mass tag (TMT) analysis of the aortic arch revealed that integrin alpha 3 (ITGA-3) and ITGA-5 could be the target proteins of AD among 100 down-regulated proteins.[63]
In proteomics, there are findings in MFS also, in addition to the study of AD. MFS is a heritable disorder of the connective tissue whose most life-threatening manifestation is AD. Using proteomic techniques, Pilop et al identified upregulation of the filamin A C-terminal fragment in aortic media of MFS patients suffering from an aneurysm of the ascending aorta.[64] Another study that investigated the glycoproteomics of MFS showed that microfibril-associated glycoprotein 4 (MFAP4) glycosylation was enhanced in advanced aneurysms of MFS compared with control aneurysms of patients without MFS, and its expression was also enhanced.[65] The research team further conducted a retrospective study of the role of MFAP4 in Marfan syndrome. They found that MFAP4 expression is upregulated by TGF-β in MFS.[66]
These proteomic data provide novel biomarkers for diagnosing AD and improving the accuracy of existing diagnostic strategies. However, proteomic research on AD is still in the developmental stage, and many technologies, such as protein separation, need to be improved further.
Metabolomics is the scientific study of chemical processes that involve metabolites, small-molecule substrates, intermediates, and cellular metabolites. Specifically, it is the study of the metabolic spectrum of small molecules for specific cellular processes.[67] Metabolomics is a relatively recent development in this domain but has already proven its high efficacy in many clinical areas, such as the evaluation and personalization of drug therapy. Recently, several studies have explored the metabolite profiles of AD patients.
Researchers have identified serum metabolomic markers with the potential to diagnose AD and distinguish between the two subtypes of AD through metabolomic approaches. They analyzed the plasma metabolome of different samples by ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. They found that in patients with AD, lysophosphatidylcholines (LPCs) and sphingolipids were significantly altered, whereas with sphingolipids, such as sphinganine, phytosphingosine, and ceramide significantly reduced in patients with Stanford type A AD group.[68] The combination of these two metabolite families can be used as potential biomarkers for diagnosing AD and distinguishing Stanford A from Stanford B.
Other researchers have studied new pathological mechanisms and potential biomarkers of AD by analyzing the overall metabolic profile of patients with AD. They compared plasma metabolites in AD, AA, and regular groups and found that sphingolipids, especially their core metabolite C18 ceramide, were significantly increased in TAD patients.[69] Then they demonstrated that C18-Ceramide plays an important role in TAD by aggravating aortic inflammation through the NLRP3 pathway in mice and in vitro. Conversely, Lian et al also used metabolomics and Seahorse extracellular flux analysis to examine the metabolic status of macrophages involved in AD. Macrophage metabolism is reprogrammed in AD, thereby inducing HIF-1α activation. These experimental results suggest that macrophage HIF-1α may be a potential therapeutic target for AD.[70]
Significant progress has been made in the study of metabolomics in AD, however, there are still shortcomings and deficiencies. The research conducted so far mainly analyzed the differences in lipids in the metabolome in AD, and there is still a lack of research on the mechanism. Future studies should further analyze the signaling pathways of different products in the metabolome, to identify more effective targets for the treatment of AD. Although metabolomics was developed after genomics and transcriptomics, it has become an important supplement to genomics and transcriptomics because of its low cost and wide detection range.
Discussion
Single- and multi-omics datasets have been widely used in aortic dissection research, to find biomarker signatures, discover disease subtypes, predict response to therapy, and for functional omics studies (Figure.1). However, various mono mics have their limitations. DNA sequencing can clarify the differences and similarities in coding sequences. In addition, RNA expression, protein structure and activity cannot be determined by gene sequencing. An insufficient genetic pool and positive pathological samples also constrain genetic and phenotypic associations. Double-strand RNA-mediated RNAi-specific gene silencing by specific enzymes can block gene expression at transcriptional, post-transcriptional and translational levels. Shortcomings of current transcriptomics technology are that: RNA does not reach protein in a 1:1 ratio after RNA transcription, degradation, translation and post-translational modification, so it is essential to evaluate proteins and their concentrations, interactions and positions. The protein concentration, activity, and compensation effect of similar proteins in proteomics may affect the study results, and small-molecule substances in metabolomics can compensate for this deficiency.
Figure 1: Application of multi-omics research in aortic dissection.
Presently, high throughput sequencing technology has become a popular research topic. Traditional gene expression analysis techniques, such as quantitative polymerase chain reaction, microarrays, and mass RNA sequencing, tend to examine a population of cells that are heterogeneous in their gene expression levels and find the average of their gene expression levels. However, such detection is not appropriate for subsets of cells with relatively low content ignored in conventional RNA sequencing detection and for different individual cells in the cell population.[71] To overcome this constraint, single-cell sequencing, which refers to the sequencing and analysis of genomes and transcriptomes at the single-cell level has been developed. In recent years, studies of AD based on single-cell RNA sequencing have also been conducted. This method can be used to discover new markers of AD. Liu et al identified Il1rn+/ Trem1+ macrophage subsets as cellular targets that slow the progression of thoracic aortic aneurysms and dissections, by sequencing thoracic aortic cells in a mouse model using single-cell technology.[72] In addition, another research group revealed the heterogeneity of experimental AD of smooth muscle cells using single-cell RNA sequencing, and also identified 15 cell clusters and nine cell types.[73]
The pathogenesis of AD is complex. While the idea of single omics is sufficiently mature to obtain definitive analytical results that systematically answer biological questions and explain mechanisms, the introduction of multi-omics is the result of integrating single omics. An in-depth understanding of the pathogenesis of AD will undoubtedly assist in the exploration of new biomarkers for prevention, diagnosis, and treatment as well as promote the development of new drugs, and ultimately, the development of AD research.
It is believed that with the development and maturity of various technologies, the cost will gradually decrease and multi-omics applications will become more widespread. In the future, multi-omics will become a pilot application of AD research and promote progress in precision medicine.
CRediT authorship contribution statement
XYZ, XJ, YYW and QJZ contributed to the revision of the final manuscript. All authors read and approved the final version of the manuscript. XYZ and XJ contributed equally to this work.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
Acknowledgments
We would like to thank all the colleagues in our laboratories (Department of Cardiovascular Surgery, The First Affiliated Hospital, School of Medicine, Southern University of Science and Technology), for their help and support.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.
My experience publishing in Psychology and Mental Health Care was exceptional. The peer review process was rigorous and constructive, with reviewers providing valuable insights that helped enhance the quality of our work. The editorial team was highly supportive and responsive, making the submission process smooth and efficient. The journal's commitment to high standards and academic rigor makes it a respected platform for quality research. I am grateful for the opportunity to publish in such a reputable journal.
My experience publishing in International Journal of Clinical Case Reports and Reviews was exceptional. I Come forth to Provide a Testimonial Covering the Peer Review Process and the editorial office for the Professional and Impartial Evaluation of the Manuscript.
